Flashback to the 1960s: LSD in the treatment of autism

  title={Flashback to the 1960s: LSD in the treatment of autism},
  author={Jeff Sigafoos and Vanessa A. Green and Chaturi D Edrisinha and Giulio E. Lancioni},
  journal={Developmental Neurorehabilitation},
  pages={75 - 81}
Between 1959 and 1974, several groups of researchers issued reports on the use of d-Lysergic Acid Diethylamide (LSD) in the treatment of children with autism. This paper reviews that literature to consider how the authors justified these studies, as well as their methods, results, and conclusions. The justification for using LSD was often based on the default logic that other treatment efforts had failed. Several positive outcomes were reported with the use of LSD, but most of these studies… Expand
From Psychiatry to Flower Power and Back Again: The Amazing Story of Lysergic Acid Diethylamide.
  • H. Mucke
  • Psychology, Medicine
  • Assay and drug development technologies
  • 2016
Using today's tools of molecular pharmacology, functional imaging, and neuronal network theory, neuropsychiatry is now resurrecting LSD research-with implications that leave us with many medical and ethical questions. Expand
A review of recent reports on autism: 1000 studies published in 2007
Characteristics of these children include selective (inward) attention; underresponsiveness; stereotyped repetitive motor behavior; increased head size, weight, and height; various cognitive and communicative disorders; and also epilepsy. Expand
MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults
Infrequent dosing of MDMA mitigates adverse event frequency and improves the risk/benefit ratio of MDMA, which may provide a significant advantage over medications that require daily dosing. Expand
Chapter 10 History of autism spectrum disorders
Child psychiatrist Leo Kanner (pronounced “Konner;” Feinstein, 2010, p. 19) published a ground-breaking paper in 1943 that introduced the world to the present-day concept of autism (Fombonne, 2003;Expand
Pivotal Response Treatment
An overview of an evidence-based treatment, Pivotal Response Treatment (PRT), for autism spectrum disorder (ASD), and how activities were designed, using principles of PRT, to target skill acquisition are outlined. Expand
Blood oxygen level–dependent functional magnetic resonance imaging and magnetoencephalography have been employed for in vivo brain imaging in humans after administration of a psychedelic, and results indicate that intravenously administered psilocybin and LSD produce decreases in oscillatory power in areas of the brain’s default mode network. Expand
Perceptions of the medicinal value of hallucinogenic drugs among college students
Perceptions among college students about the potential medicinal benefits of hallucinogenic drugs, including an ability to help anxiety, post-traumatic stress disorder, and addiction with hallucinogen-assisted psychotherapy, are examined. Expand
The Therapeutic Potential of Psilocybin
The potential of psilocybin in the treatment of neuropsychiatry-related conditions is explored, examining recent advances as well as current research. Expand
Video-based intervention for individuals with Autism
This doctoral research investigated video-based intervention (VBI) for individuals with autism. Without effective intervention, individuals with autism are likely to experience difficulties withExpand
Video-based intervention for individuals with autism: Key questions that remain unanswered
Abstract Research on variations of video-based intervention (VBI) suggests that they can be effective for teaching individuals with disabilities a range of socially significant behaviors. Among theExpand


The use of psychedelic agents with autistic schizophrenic children.
In recent years, a number of exploratory investigations have been reported involving the administration of psychedelic agents to young children suffering from severe forms of psychologicalExpand
Autistic schizophrenic children. An experiment in the use of d-lysergic acid diethylamide (LSD-25).
This work concludes that the LSD experience cannot be equated with naturally occurring psychosis and that the drug should not be used as an adjunct to psychotherapy. Expand
Treatment of autistic schizophrenic children with LSD-25 and UML-491.
The various treatment regimes attempted by Bender and co-workers in the past quarter of a century with autistic schizophrenic children are referred to. Expand
The Science and Fiction of Autism
Autism is a complex and incurable constellation of bizarre behaviours, impaired cognition, limited language and most distressingly, a lack of responsiveness to other people, and it has been theExpand
A Clinical Plan for MDMA (Ecstasy) in the Treatment of Posttraumatic Stress Disorder (PTSD): Partnering with the FDA
  • R. Doblin
  • Medicine
  • Journal of psychoactive drugs
  • 2002
Abstract The FDA and the Spanish Ministry of Health have concluded that the risk/benefit ratio is favorable under certain circumstances for clinical studies investigating MDMA-assisted psychotherapy.Expand
The Renewal of Psychedelic Research: Implications for Humanistic and Transpersonal Psychology
A number of medication trials at major U.S. research universities are now, once more, legally exploring psychedelics' vast potential for treating various physical and psychological problems. TheseExpand
LSD, my problem child
Numerous accounts of the discovery of LSD have been published in English; none, unfortunately, have been completely accurate. Here, at last, the father of LSD details the history of his "problemExpand
Behavioral treatment and normal educational and intellectual functioning in young autistic children.
  • O. I. Lovaas
  • Medicine, Psychology
  • Journal of consulting and clinical psychology
  • 1987
The results of behavior modification treatment for two groups of similarly constituted, young autistic children showed that 47% achieved normal intellectual and educational functioning, with normal-range IQ scores and successful first grade performance in public schools. Expand
Intensive behavioral treatment for children with autism: four-year outcome and predictors.
After combining groups, it was found that 48% of all children showed rapid learning, achieved average posttreatment scores, and at age 7, were succeeding in regular education classrooms. Expand
Interventions for Children and Youth with Autism
This article discusses intervention and treatment options being used with the population of children and youth who have autism spectrum disorders. The discussion includes interventions based onExpand